Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

399 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relationship between the number of drugs used during percutaneous coronary intervention and adverse events in patients with chronic coronary syndrome: Analysis of CLIDAS database.
Hitomi Y, Imai Y, Kuwabara M, Oba Y, Kabutoya T, Kario K, Makimoto H, Kohro T, Shiraki E, Akashi N, Fujita H, Matoba T, Miyamoto Y, Kiyosue A, Tsujita K, Nakayama M, Nagai R; CLIDAS research group. Hitomi Y, et al. Among authors: oba y. Int J Cardiol Heart Vasc. 2024 Sep 12;54:101507. doi: 10.1016/j.ijcha.2024.101507. eCollection 2024 Oct. Int J Cardiol Heart Vasc. 2024. PMID: 39314922 Free PMC article.
Hyperuricemia predicts increased cardiovascular events in patients with chronic coronary syndrome after percutaneous coronary intervention: A nationwide cohort study from Japan.
Akashi N, Kuwabara M, Matoba T, Kohro T, Oba Y, Kabutoya T, Imai Y, Kario K, Kiyosue A, Mizuno Y, Nochioka K, Nakayama M, Iwai T, Nakao Y, Iwanaga Y, Miyamoto Y, Ishii M, Nakamura T, Tsujita K, Sato H, Fujita H, Nagai R. Akashi N, et al. Among authors: oba y. Front Cardiovasc Med. 2023 Jan 10;9:1062894. doi: 10.3389/fcvm.2022.1062894. eCollection 2022. Front Cardiovasc Med. 2023. PMID: 36704454 Free PMC article.
Sex Differences in Long-Term Outcomes in Patients With Chronic Coronary Syndrome After Percutaneous Coronary Intervention　- Insights From a Japanese Real-World Database Using a Storage System.
Akashi N, Matoba T, Kohro T, Oba Y, Kabutoya T, Imai Y, Kario K, Kiyosue A, Mizuno Y, Nochioka K, Nakayama M, Iwai T, Miyamoto Y, Ishii M, Nakamura T, Tsujita K, Sato H, Fujita H, Nagai R; CLIDAS Research Group. Akashi N, et al. Among authors: oba y. Circ J. 2023 May 25;87(6):775-782. doi: 10.1253/circj.CJ-22-0653. Epub 2023 Jan 28. Circ J. 2023. PMID: 36709982 Free article.
Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events.
Ikebe S, Ishii M, Otsuka Y, Nakamura T, Tsujita K, Matoba T, Kohro T, Oba Y, Kabutoya T, Imai Y, Kario K, Kiyosue A, Mizuno Y, Nochioka K, Nakayama M, Iwai T, Miyamoto Y, Sato H, Akashi N, Fujita H, Nagai R; CLIDAS research group. Ikebe S, et al. Among authors: oba y. Int J Cardiol Cardiovasc Risk Prev. 2023 Jun 25;18:200193. doi: 10.1016/j.ijcrp.2023.200193. eCollection 2023 Sep. Int J Cardiol Cardiovasc Risk Prev. 2023. PMID: 37415925 Free PMC article.
BNP level predicts bleeding event in patients with heart failure after percutaneous coronary intervention.
Otsuka Y, Ishii M, Ikebe S, Nakamura T, Tsujita K, Kaikita K, Matoba T, Kohro T, Oba Y, Kabutoya T, Kario K, Imai Y, Kiyosue A, Mizuno Y, Nochioka K, Nakayama M, Iwai T, Miyamoto Y, Sato H, Akashi N, Fujita H, Nagai R; CLIDAS research group. Otsuka Y, et al. Among authors: oba y. Open Heart. 2023 Dec 7;10(2):e002489. doi: 10.1136/openhrt-2023-002489. Open Heart. 2023. PMID: 38065584 Free PMC article.
Change in pulse pressure and cardiovascular outcomes after percutaneous coronary intervention: The CLIDAS study.
Nochioka K, Nakayama M, Akashi N, Matoba T, Kohro T, Oba Y, Kabutoya T, Imai Y, Kario K, Kiyosue A, Mizuno Y, Iwai T, Miyamoto Y, Ishii M, Nakamura T, Tsujita K, Sato H, Fujita H, Nagai R; CLIDAS research group. Nochioka K, et al. Among authors: oba y. Int J Cardiol Heart Vasc. 2024 May 24;53:101430. doi: 10.1016/j.ijcha.2024.101430. eCollection 2024 Aug. Int J Cardiol Heart Vasc. 2024. PMID: 39228973 Free PMC article.
Achievement of guideline-recommended target blood pressure is associated with reducing the risk of hemorrhagic and ischemic stroke in Japanese coronary artery disease patients -the CLIDAS study.
Oba Y, Kabutoya T, Kohro T, Imai Y, Kario K, Sato H, Nochioka K, Nakayama M, Akashi N, Fujita H, Mizuno Y, Kiyosue A, Iwai T, Miyamoto Y, Nakano Y, Ishii M, Nakamura T, Tsujita K, Matoba T, Nagai R; CLIDAS research group. Oba Y, et al. Hypertens Res. 2024 Sep 19. doi: 10.1038/s41440-024-01902-5. Online ahead of print. Hypertens Res. 2024. PMID: 39300294
Corrigendum to "Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events" [Int. J. Cardiol. Cardiovasc. Risk and Prev. 2023 Jun 25:18:200193].
Ikebe S, Ishii M, Otsuka Y, Nakamura T, Tsujita K, Matoba T, Kohro T, Oba Y, Kabutoya T, Imai Y, Kario K, Kiyosue A, Mizuno Y, Nochioka K, Nakayama M, Iwai T, Miyamoto Y, Sato H, Akashi N, Fujita H, Nagai R; of the CLIDAS research group. Ikebe S, et al. Among authors: oba y. Int J Cardiol Cardiovasc Risk Prev. 2024 Jul 5;22:200304. doi: 10.1016/j.ijcrp.2024.200304. eCollection 2024 Sep. Int J Cardiol Cardiovasc Risk Prev. 2024. PMID: 39280775 Free PMC article.
399 results